Although US stocks closed higher on Friday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock

How to Find Penny Stocks to Buy in Summer 2022

03:30pm, Saturday, 16'th Jul 2022 PennyStocks
Use these tips to find penny stocks to buy this Summer The post How to Find Penny Stocks to Buy in Summer 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

How to Find Penny Stocks to Buy in Summer 2022

11:30am, Saturday, 16'th Jul 2022
Use these tips to find penny stocks to buy this Summer The post How to Find Penny Stocks to Buy in Summer 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Gainers Clene Inc. (NASDAQ: CLNN) shares jumped 43.4% to close at $4.13. Clene reported significantly improved survival in Amyotrophic lateral sclerosis (ALS) patients initially treated with CNM-Au8
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th. Liberty TripAdvisor Holdings
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th. ironSource Ltd. (NYSE: IS) gained 48.
The mean of analysts' price targets for Gossamer Bio (GOSS) points to an 113.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among a

Gossamer Bio (GOSS) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

01:55pm, Monday, 23'rd May 2022 Zacks Investment Research
After losing some value lately, a hammer chart pattern has been formed for Gossamer Bio (GOSS), indicating that the stock has found support. This, combined with an upward trend in earnings estimate re

Where Gossamer Bio Stands With Analysts

04:08pm, Tuesday, 26'th Apr 2022 Benzinga
Analysts have provided the following ratings for Gossamer Bio (NASDAQ:GOSS) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 La
Gossamer Bio Inc (NASDAQ: GOSS) shares are falling after announcing topline results from its Phase 2 SHIFT-UC Study trial of GB004 in patients with mild-to-moderate active ulcerative colitis (UC).
Upgrades For PBF Energy Inc (NYSE:PBF), Scotiabank upgraded the previous rating of Sector Underperform to Sector Perform. For the fourth quarter, PBF Energy had an EPS of $1.28, compared to year-ago q

Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022

02:16pm, Wednesday, 06'th Apr 2022 Benzinga
Upgrades According to Morgan Stanley, the prior rating for Royalty Pharma PLC (NASDAQ:RPRX) was changed from Equal-Weight to Overweight. In the fourth quarter, Royalty Pharma showed an EPS of $0.80, c

Gossamer Bio GAAP EPS of -$0.74 misses by $0.02

10:34pm, Thursday, 03'rd Mar 2022 Seeking Alpha
Gossamer Bio press release (GOSS): Q4 GAAP EPS of -$0.74 misses by $0.02.Cash, cash equivalents and marketable securities totaled $325 million at year-end 2021.

Gossamer Bio files for mixed shelf offering

10:12pm, Thursday, 03'rd Mar 2022 Seeking Alpha
Gossamer Bio (GOSS) has filed for a mixed shelf offering of a yet to be determined amount.
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced its financial results for the fourth quarter and year ended December 31, 2021 and provided a business update. “After a considerable amount of planning and effort, the Gossamer team is excited to enter 2022 with two ongoing Phase 2 tria
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE